Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study
- Jun Te Hsu*
- , Puo Hsien Le
- , Chang Fu Kuo
- , Meng Jiun Chiou
- , Chia Jung Kuo
- , Tsung Hsing Chen
- , Chun Jung Lin
- , Jen Shi Chen
- , Huang Pin Yu
- , Chun Nan Yeh
- , Yi Yin Jan
- , Ta Sen Yeh
*此作品的通信作者
研究成果: 期刊稿件 › 文章 › 同行評審
9
引文
斯高帕斯（Scopus）